This program consists of 2 modules:
Provided by Imedex®, LLC.
This activity is supported by educational grants from Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc. and TG Therapeutics.
Topic: Hematology/Oncology, Oncology
Target Audience: This educational activity is designed for US-based hematologists, medical oncologists, hematopathologists, other healthcare professionals interested in the therapeutic management of hematologic malignancies.